Katrien Verschueren

725 total citations
7 papers, 336 citations indexed

About

Katrien Verschueren is a scholar working on Radiology, Nuclear Medicine and Imaging, Hematology and Oncology. According to data from OpenAlex, Katrien Verschueren has authored 7 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Hematology and 2 papers in Oncology. Recurrent topics in Katrien Verschueren's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Platelet Disorders and Treatments (3 papers) and Blood groups and transfusion (2 papers). Katrien Verschueren is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Platelet Disorders and Treatments (3 papers) and Blood groups and transfusion (2 papers). Katrien Verschueren collaborates with scholars based in Belgium, Hungary and United States. Katrien Verschueren's co-authors include Josefin-Beate Holz, Peter de Jaegere, Karen Silence, Femke Van Bockstaele, Stefaan Rossenu, Judith Baumeister, Peter Casteels, Sofie Priem, Patrick Stanssens and Anne Schoolmeester and has published in prestigious journals such as Blood, Annals of the Rheumatic Diseases and Human Reproduction.

In The Last Decade

Katrien Verschueren

7 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katrien Verschueren Belgium 6 150 117 99 62 50 7 336
Riccardo Mancini Italy 11 70 0.5× 75 0.6× 96 1.0× 46 0.7× 28 0.6× 17 352
GR Burmester Germany 10 49 0.3× 248 2.1× 66 0.7× 50 0.8× 42 0.8× 28 495
F Navaux France 6 59 0.4× 133 1.1× 39 0.4× 51 0.8× 36 0.7× 9 357
Helle Laustrup Denmark 9 16 0.1× 326 2.8× 53 0.5× 33 0.5× 84 1.7× 15 482
Francesca Lunghi Italy 8 109 0.7× 148 1.3× 12 0.1× 66 1.1× 85 1.7× 19 378
F H Gmelig Meyling Netherlands 6 82 0.5× 230 2.0× 223 2.3× 40 0.6× 39 0.8× 7 403
Gerardo Orozco‐Barocio Mexico 10 15 0.1× 136 1.2× 32 0.3× 41 0.7× 45 0.9× 23 305
Panagiotis Garantziotis Greece 11 46 0.3× 217 1.9× 67 0.7× 34 0.5× 50 1.0× 26 402
Anum Fayyaz United States 3 71 0.5× 120 1.0× 37 0.4× 31 0.5× 51 1.0× 7 348
Thierry Fulpius Switzerland 11 90 0.6× 189 1.6× 159 1.6× 101 1.6× 18 0.4× 16 393

Countries citing papers authored by Katrien Verschueren

Since Specialization
Citations

This map shows the geographic impact of Katrien Verschueren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrien Verschueren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrien Verschueren more than expected).

Fields of papers citing papers by Katrien Verschueren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrien Verschueren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrien Verschueren. The network helps show where Katrien Verschueren may publish in the future.

Co-authorship network of co-authors of Katrien Verschueren

This figure shows the co-authorship network connecting the top 25 collaborators of Katrien Verschueren. A scholar is included among the top collaborators of Katrien Verschueren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrien Verschueren. Katrien Verschueren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Newland, Adrian C., Blanca Sánchez‐González, László Rejtő, et al.. (2019). Phase 2 Study of Efgartigimod, a Novel FcRn Antagonist, in Adult Patients with Primary Immune Thrombocytopenia. Blood. 134(Supplement_1). 895–895. 9 indexed citations
2.
Newland, Adrian C., Blanca Sánchez‐González, László Rejtő, et al.. (2019). Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia. American Journal of Hematology. 95(2). 178–187. 129 indexed citations
3.
Decleer, W., Kaan Osmanagaoglu, Katrien Verschueren, Frank Comhaire, & Paul Devroey. (2016). RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. Human Reproduction. 31(9). 2017–2023. 32 indexed citations
4.
Beneden, Katrien Van, et al.. (2014). FRI0329 Impact of Clinical Remission on Physical Function in Patients with Rheumatoid Arthritis Treated with Alx-0061: Post-Hoc Analysis of Phase I/Ii Data. Annals of the Rheumatic Diseases. 73. 506–506. 1 indexed citations
5.
Holz, Josefin-Beate, Bernadette Rojkovich, Mariusz Korkosz, et al.. (2013). OP0043 Twenty-Four Weeks of Treatment with a Novel Anti-IL-6 Receptor Nanobody® (ALX-0061) Resulted in 84% ACR20 Improvement and 58% DAS28 Remission in a Phase I/Ii Study in RA. Annals of the Rheumatic Diseases. 72. A64–A64. 18 indexed citations
6.
7.
Ulrichts, Hans, Karen Silence, Anne Schoolmeester, et al.. (2011). Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs. Blood. 118(3). 757–765. 140 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riccardo Mancini Breakdown of academic impact, for papers by GR Burmester Breakdown of academic impact, for papers by F Navaux Breakdown of academic impact, for papers by Helle Laustrup Breakdown of academic impact, for papers by Francesca Lunghi Breakdown of academic impact, for papers by F H Gmelig Meyling Breakdown of academic impact, for papers by Gerardo Orozco‐Barocio Breakdown of academic impact, for papers by Panagiotis Garantziotis Breakdown of academic impact, for papers by Anum Fayyaz Breakdown of academic impact, for papers by Thierry Fulpius
Rankless by CCL
2026